T1	Measurement 20 31;38 53	hepatitis B surface antigen
T2	Value 11 19	positive
T3	Measurement 62 69	HBV DNA
*	OR T1 T3
T4	Temporal 70 89	prior to enrollment
T5	Reference_point 79 89	enrollment
R3	Has_index Arg1:T4 Arg2:T5	
T6	Scope 20 69	hepatitis B (HBV) surface antigen, and/or HBV DNA
R1	Has_value Arg1:T6 Arg2:T2	
R2	Has_temporal Arg1:T6 Arg2:T4	
T7	Procedure 113 143	HCV protease inhibitor therapy
T8	Condition 145 161	HIV co-infection
T9	Drug 170 188	protease inhibitor
R4	AND Arg1:T8 Arg2:T9	
T10	Measurement 216 226	creatinine
T11	Value 204 212;227 244	Increase of 15% or greater
R5	Has_value Arg1:T10 Arg2:T11	
T12	Temporal 245 261	within one month
T13	Temporal 263 270	30 days
R6	Subsumes Arg1:T12 Arg2:T13	
R7	Has_temporal Arg1:T10 Arg2:T12	
T14	Condition 308 332	hepatocellular carcinoma
T15	Condition 360 373	Liver disease
T16	Negation 396 401	other
T17	Observation 407 410	HCV
R8	Has_negation Arg1:T17 Arg2:T16	
T18	Condition 418 441	decompensated cirrhotic
T19	Observation 412 414	F4
*	OR T18 T19
T20	Measurement 477 480	AST
T21	Measurement 484 487	ALT
T22	Value 488 492	>350
T23	Temporal 493 528	within 6 months prior to enrollment
T24	Reference_point 518 528	enrollment
R9	Has_index Arg1:T23 Arg2:T24	
*	OR T20 T21
T25	Scope 477 487	AST or ALT
R10	Has_value Arg1:T25 Arg2:T22	
R11	Has_temporal Arg1:T25 Arg2:T23	
T26	Measurement 452 468	Child Pugh class
T27	Value 469 475	B or C
R12	Has_value Arg1:T26 Arg2:T27	
T28	Measurement 530 537	Albumin
T29	Value 538 545	< 3g/dL
R13	Has_value Arg1:T28 Arg2:T29	
T30	Measurement 573 587	Platelet count
T31	Value 588 592	< 75
R14	Has_value Arg1:T30 Arg2:T31	
T32	Condition 654 661	allergy
T33	Condition 665 678	adverse event
T34	Drug 684 703	protease inhibitors
*	OR T33 T32
T35	Scope 654 678	allergy or adverse event
R15	AND Arg1:T35 Arg2:T34	
T36	Condition 721 739	acquisition of HCV
T37	Temporal 740 779	at the time of or after transplantation
T38	Reference_point 764 779	transplantation
R16	Has_index Arg1:T37 Arg2:T38	
R17	Has_temporal Arg1:T36 Arg2:T37	
T39	Pregnancy_considerations 781 812	Pregnant or breastfeeding women
T40	Drug 814 826	Cyclosporine
T41	Drug 828 843	St. John's Wort
T42	Drug 845 854	Efavirenz
T43	Drug 856 865	Phenytoin
T44	Drug 867 880	Carbamazepine
T45	Drug 882 890	Bosentan
T46	Drug 892 915	HIV protease inhibitors
T47	Drug 917 926	modafinil
T48	Drug 928 940	ketoconazole
T49	Drug 945 953	rifampin
T50	Temporal 958 985	within 7 days of enrollment
T51	Reference_point 975 985	enrollment
R18	Has_index Arg1:T50 Arg2:T51	
*	OR T40 T41 T42 T43 T44 T45 T46 T47 T48 T49
T52	Scope 814 953	Cyclosporine; St. John's Wort; Efavirenz; Phenytoin; Carbamazepine; Bosentan; HIV protease inhibitors; modafinil; ketoconazole; or rifampin
R19	Has_temporal Arg1:T52 Arg2:T50	
T53	Multiplier 1007 1022	more than 20 mg
T54	Drug 1023 1035	atorvastatin
T55	Multiplier 1007 1016;1037 1042	more than 10 mg
T56	Multiplier 1007 1016;1057 1062	more than 20 mg
R20	Has_multiplier Arg1:T54 Arg2:T53	
T57	Drug 1043 1055	rosuvastatin
T58	Drug 1066 1077	fluvastatin
T59	Drug 1079 1089	lovastatin
T60	Drug 1093 1104	simvastatin
*	OR T60 T59 T58
T61	Scope 1066 1104	fluvastatin, lovastatin or simvastatin
R21	Has_multiplier Arg1:T61 Arg2:T56	
R22	Has_multiplier Arg1:T57 Arg2:T55	
*	OR T54 T57 T61
